Correlation Between Changes in Psoriasis Severity Score and Quality of Life Before and After Treatment in Psoriasis Vulgaris Patients

Authors

  • Tessa Thendria Departement of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
  • Afif Nurul Hidayati Departement of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Aca-demic Hospital, Surabaya, Indonesia
  • Diah Mira Indramaya Departement of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
  • Dwi Murtiastutik Departement of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
  • Rahmadewi Departement of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
  • Budi Utomo Departement of Public Health and Preventive Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
  • Menul Ayu Umborowati Departement of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
  • Cita Rosita Sigit Prakoeswa Departement of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, Indonesia

Keywords:

psoriasis vulgaris, dermatology life quality index, psoriasis severity index

Abstract

Background:  Psoriasis not only causes physical comorbidities but also leads to psychological problems in patients. The severity of the disease is believed to be related to the patient's quality of life. However, research on the relationship between PASI and DLQI often shows inconsistent results. Evaluation of changes in PASI and DLQI scores is expected to provide an overview of the relationship between changes in disease severity and improvements in the patient's quality of life after therapy. Objective:  To evaluate the relationship between changes in PASI and DLQI score in patients with psoriasis vulgaris at Department of Dermatology and Venereology, Dr. Soetomo General Hospital, Surabaya, Indonesia. Methods:  This was a retrospective study with a cross-sectional approach. This research included a total of 50 newly diagnosed psoriasis vulgaris patients who met the inclusion criteria and received treatment from January 2021 to July 2023. Results:  A significant correlation was found between PASI and DLQI scores prior to treatment (p=0.001; r=0.483). A marked improvement was observed in both PASI and DLQI scores after treatment (p=0.001; p=0.001 respectively). However, no significant correlation was observed between PASI and DLQI scores after treatment (p=0.209), nor was there a significant correlation between changes in disease severity (ΔPASI) and QoL (ΔDLQI) following therapy (p=0.120). Conclusion:  Improvements in disease severity for psoriasis vulgaris do not consistently translate into better quality of life for patients. Therefore, regular QoL evaluations and psychological support are essential for all patients, regardless of the degree of severity and the changes of PASI score.

Author Biography

Afif Nurul Hidayati, Departement of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Aca-demic Hospital, Surabaya, Indonesia

Professor of dermatology and venereology, Departement of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/ Dr. Soetomo General Academic Hospital, Surabaya, Indonesia  

References

Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: System-atic analysis and modelling study. BMJ. 2020;28(1) : 369:m1590. doi: 10.1136/bmj.m1590.

Hidayati AN, Hendaria MP, Listiawan MY, Utomo B, Damayanti D, Prakoeswa CRS, et al. The profile of psoriasis vulgaris patients: A descriptive study. Berkala Ilmu Kesehatan Kulit dan Kelamin. 2021;33(3):173-81. doi.10.20473/bikk.V33.3.2021.173-181

Hendaria MP, Hidayati AN, Ervianti E, Listiawan MY, Damayanti, Citrashanty I, et al. Clinical impro-vement of patients with moderate-to-severe psoria-sis treated with methotrexate at Dr. Soetomo Gen-eral Hospital, Surabaya, Indonesia. Bali Med. J. 2022;11(1):328–33. doi.10.15562/bmj.v11i1.3417.

Leonardi C, See K, Gallo G, McKean-Matthews M, Zhang Y, Goldblum O, et al. Psoriasis severity ass-essment combining physician and patient reported outcomes: the optimal psoriasis assessment tool. Dermatol Ther (Heidelb). 2021; 11(4):1249-63. doi: 10.1007/s13555-021-00544-6

Zhang XJ, Lin JR, Ou MX, Yan HW, Liu SN, Dai L, et al. Factors associated with quality of life in Chin-ese people with psoriasis: a cross-sectional study. BMC Public Health. 2023 25;23(1):1860. doi: 10.1186 /s12889-023-16758-6

Gonzaga H, Gigliotti M, Gonzaga MLJ de S, Marcos EVC, Covolo F, Santana FC de S, et al. Psoriasis area and severity index (PASI) and dermatological life quality index (DLQI) correlation in patients with cutaneous psoriasis. International Journal of De-velopment Research. 2022;12(09):58679–83. doi.org/ 10.37118/ijdr.25322.09.2022.

Zou Q, Luo Y, Hao D, Li M, Jihui C. Validation and application of the Dermatology Life Quality Index score, a modification of the DLQI score, in psoriasis patients J Health Popul Nutr. 2024;22;43(1):92. doi: 10.1186/s41043-024-00587-3

Silva MF, Fortes MR, Miot LD, Marques SA. Psoria-sis: correlation between severity index (PA-SI) and quality of life index (DLQI) in patients assessed bef-ore and after systemic treatment. An Bras Dermatol. 2013;88(5):760–3. doi: 10.1590/abd1806-4841.20 132052.

Rahmayanti ND, Hidayati AN, Ervianti E, Muhdi N. Association of psoriasis severity degree with self-esteem, depression and dermatology life quali-ty index. J Pak Assoc Dermatol.2019;30(1):117–27.

Hesselvig JH, Egeberg A, Loft ND, Zachariae C, Kofoed K, Skov L. Correlation between dermatology life quality index and psoriasis area and severity index in patients with psoriasis treated with ustekinumab Acta Derm Venereol.. 2018;98(3): 335-9. doi: 10.2340/00015555-2833

Umborowati MA, Syamsuri A, Endaryanto A, Sur-ono IS, Thio HB, Prakoeswa CRS. Correlation bet-ween disease severity and quality of life index in psoriasis patients treated with Lactobacillus plantarum IS-10506. Int J of Health Sci. 2022;23:2433–43. doi.org/10.53730/ijhs.v6nS9.12957

Nowowiejska J, Baran A, Grabowska P, Lewoc M, Kaminski TW, Flisiak I. Assessment of Life Quality, Stress and Physical Activity Among Patients with Psoriasis. Dermatol Ther (Heidelb). 2022;12(2):395–406. doi: 10.1007/s13555-021-00662-1

Torres RA, Silva SA, Magalhães RF, Morcillo AM, Velho PE. Comparison of quality-of-life question-naires and their correlation with the clinical course of patients with psoriasis. An Bras Dermatol. 2011;86(1):45-9. doi: 10.1590/s0365-0596201100010 0005.

Mattei PL, Corey KC, Kimball AB. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The correlation between dis-ease severity and psychological burden in patients treated with biological therapies. J Eur Acad Der-matol Venereol. 2014;28(3):333–7. doi: 10.1111/jdv. 12106.

Agarwal K, Das A, Das S, De A. Impact of psoriasis on quality of life Indian J Dermatol. 2022 ;67(4):387-91. doi: 10.4103/ijd.ijd_572_22.

Rompoti N, Tsiori S, Kontoangelos K, Kouzoupis A, Papageorgiou C, Gregoriou S, et al. Rigopoulos D. Psychopathological profile of patients with moder-ate-to-severe plaque psoriasis and its correlation to dlqi: results from a prospective, monocentric clini-cal study. J Clin Med. 2024 ;13(21):6424.

doi: 10.3390/jcm13216424

Kirsten N, Rustenbach S, von Kiedrowski R, Sorbe C, Reich K, Augustin M. Which PASI outcome is most relevant to the patients in real-world care? Life. 2021;11(11):1151.doi: 10.3390/life11111151.

Downloads

Published

2025-09-30

How to Cite

1.
Thendria T, Hidayati AN, Indramaya DM, Murtiastutik D, Rahmadewi, Utomo B, Umborowati MA, Prakoeswa CRS. Correlation Between Changes in Psoriasis Severity Score and Quality of Life Before and After Treatment in Psoriasis Vulgaris Patients. J Pak Assoc Dermatol [Internet]. 2025Sep.30 [cited 2025Nov.25];35(3):183-8. Available from: https://jpad.com.pk/index.php/jpad/article/view/2904

Issue

Section

Original Articles

Most read articles by the same author(s)

1 2 3 > >>